As of 5 pm on 6 August 2021, the final bidding day, Windlas Biotech’s public issue was subscribed 22.40 times. The company’s initial public offering received bids for 13,78,54,260 shares, whereas the total number of reserved shares was 61,36,252. Windlas Biotech is one of the leading players in India’s pharmaceutical formulations contract development and manufacturing …